==== Front Ann Saudi MedAnn Saudi MedAnnals of Saudi Medicine0256-49470975-4466King Faisal Specialist Hospital and Research Centre 2640979910.5144/0256-4947.2015.240asm-3-240Original ArticlePrevalence of fecal carriage of extended-spectrum- and metallo-β-lactamase-producing gram-negative bacteria among neonates born in a hospital setting in central Saudi Arabia Elkersh Talat aMarie Mohammed A. aAl-Sheikh Yazeed A. aBloushy Ahmad Al aAl-Agamy Mohammad H. b a Clinical Laboratory Sciences Department, King Saud University, Riyadh, Saudi Arabia b Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaCorrespondence: Prof. Mohammad H. Al-Agamy, College of Pharmacy, Department of Pharmaceutics, Microbiology Division, King Saud University, PO Box 2457 Riyadh 11451, Saudi Arabia, T: 966-553-227824, elagamy71@yahoo.comMay-Jun 2015 35 3 240 247 Copyright © 2015, Annals of Saudi Medicine2015This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.BACKGROUND AND OBJECTIVE Commensal neonatal fecal flora constitute a reservoir of antibiotic resistance. The aim of this study was to characterize the prevalence of fecal carriage of extended spectrum beta-lactamases (ESBLs) and carbapenemase producing gram-negative bacteria among 150 neonates who were born in two hospitals in central Saudi Arabia. PATIENTS AND METHODS From June 2012 to Janauary 2013, 150 healthy neonates ≤7 days of age were screened for intestinal enteric bacteria colonization and the influence of age, mode of delivery, body weight and breast feeding of neonates on colonzation rates. The isolates were identified manually and by VITEK 2 and antibiotic susceptibility was tested. Phenotypic tests were performed to seek ESBL and metallo-β-lactamase (MBL) producers in recovered isolates. RESULTS Among 150 fecal specimens, 188 gram-negative rods were recovered. E coli (n=130; 69.1%) was the commonest organism followed by Klebsiella pneumoniae (n=23; 12.2%), Pseudomonas aeuroginosa (n=14; 7.5%), Acinetobacter baumannii (n=9; 4.8%), Enterobacter spp. (n=9; 4.8%) and Morganella morganii (n=3; 1.6%). E coli colonization during the first day of life was 95.5% (n=43/45), which was relatively higher than in subsequent days. The colonization rate of E coli among low weight babies (≤3 kg) was significantly higher than fully grown neonates (≥4 kg)(P=.03). The prevalence of ESBL and MBL was 15.0% (n=28/188) and 1.6% (n=3/188). The prevalence rates of ESBL in E coli, K pneumoniae, E cloacae, M morganii and E aerogenes were 16.9% (n=22/130), 4.3 % (n=1/23), 60% (n=3/5), 33.3% (n=1/3), and 25% (n=1/4), respectively. All E cloacae with ESBLs and MBLs were resistant to all tested antibiotics including carbapenems. CONCLUSION Within the first week of life, the most important determinants of gut enteric bacteria composition in neonates were age in days, body weight, mode of delivery, and type of neonatal feeding. The findings of ESBLs- and MBLs-producing enteric bacteria as neonate-gut colonizers may have wider implication or linkage to prevention of nosocomial and community-acquired infections by these strains. ==== Body The neonatal gastrointestinal tract is considered sterile, but at birth the neonate is exposed for the first time to a wide array of bacteria from a variety of sources: from the birth canal via maternal vaginal and fecal microbiota, from the hospital environment and from handling by parents and nursing staff.1,2 The gastrointestinal microbiota play an essential role in the health and disease of the host through its impact on nutrition, pathogenesis and immunology. The gastrointestinal tract is the main reservoir and source for transmission of nosocomial pathogens, including Enterobacteriaceae.3 Previous studies have demonstrated fecal colonization by extended-spectrum -β-lactamase (ESBL)- and carbapenemase-producing Enterobacteriaceae.4–6 The first fecal colonization with ESBL-producing Enterobacteriaceae were identified in Spain in 2003.7 Since then, rates of colonization by ESBL-producing Enterobacteriaceae have increased dramatically worldwide.5,6 CTX-M-15 is the most common ESBL gene worldwide including Saudi Arabia.8 Carbapenem resistance in Enterobacteriaceae has been largely due to acquisition of carbapenemase genes, which lead to international dissemination of carbapenemase-producing Enterobacteriaceae. The most common carbapenemases are KPC, NDM, VIM, IMP and OXA-48.9–11 Previous studies reported fecal carriage of carbapenemase-producing Enterobacteriaceae.6 To the best of our knowledge there are no reports in Saudi Arabia on the fecal colonization of ESBL- and carbapenemase-producing isolates and multidrug resistant (MDR) isolates from neonates. Therefore, we conducted the present study to investigate the prevalence of fecal carriage of ESBLs and carbapenemase-producing gram-negative bacteria among 150 neonates who were born in two hospitals in central Saudi Arabia. None of the enrolled subjects nor their mothers were seriously ill and/ or hospitalized in intensive care units. Nevertheless, antibiotic use before delivery cannot be ruled out. We also assessed the risk factors (age in days, mode of delivery, body weight and type of neonatal feeding) on the prevalence of gram-negative bacteria fecal carriage. PATIENTS AND METHODS Bacterial strains Stool samples were collected from 150 neonates aged from 1–7 days at two maternity and children hospitals, Bukyriah, Qassim region, Saudi Arabia between June 2012 and January 2013. The local medical ethical committee approved the study protocol. Each parent who agreed to participate provided written informed consent and completed a questionnaire on neonatal characteristics. Epidemiological data were recorded for each neonate included type of delivery, age, weight and type of feeding. Fresh neonatal stool specimens were aseptically collected in sterile containers and immediately transported to the microbiology laboratory. Stool specimens were suspended in equal volumes of sterile phosphate buffered saline, pH 7 (PBS) and gently homogenized. Ten-fold serial dilutions were done in PBS. Aliquots (100 μL) of each dilution were directly inoculated onto blood agar and MacConkey agar (Oxoid Microbiology Products, UK). After 48 h incubation at 37°C, the recovered orgainsms were counted (colony forming units/gram of stool) and then identfied manually and by using automated identification systems of API or VITEK 2 (Biomerieux, SA, Marcy, l’Etoile, France).12 The isolates were stored in brain heart infusion broth containing 20% glycerol at −70°C. The laboratory strains, E coli ATCC 35218, K pneumoniae ATCC 700603, and P aeruginosa ATCC 27853, were used as quality control strains in antibiotic sensitivity testing. The laboratory strains, K pneumoniae ATCC700603 (positive control) and E coli ATCC25922 (negative control) were used as quality control strains in ESBL production. The laboratory strains, K pneumoniae ATCC1705 (positive control) and K pneumoniae ATCC1706 (negative control) were used as quality control strains in the Modified Hodge Test (MHT). Distribution of gram-negative bacteria by clinical characteristics of subjects To assess the effect of age on enteric bacteria colonization, neonates were categorized into four groups according to age. Group 1 comprised 45 neonates (1 day/old); group 2, 47 neonates (2 days/old); group 3, 41 neonates (3 days/old); and group 4, 17 neonates (4–7 days/old). To evaluate the influence of mode of delivery on colonization rates, the neonates were classified by vaginal (78 neonates) or cesarean (72 neonates) delivery. To assess the effect of the body weight on colonization rates, the neonates were categorized in to four groups according to weight. Group 1 comprised 4 neonates (<2 kg);group 2, 65 neonates (2–3 kg); group 3, 74 neonates (3–4 kg), and group 4, 7 neonates (>4 kg). Furthermore, to determine the rate of colonization according to the type of neonatal feeding, the neonates were classified into three groups: group 1 was breastfeeding, group 2 was bottle feeding and group 3 were mixed (bottle and breast), which included 27, 83, and 40 neonates, respectively. Antimicrobial susceptibility testing Antimicrobial susceptibility testing of 188 gram-negative rods from fecal isolates was done using the VITEK 2 system according to the manufacturer’s instructions. The results were interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guidelines for the following antibiotics:13 amikacin (AMK), ampicillin (AMP), amoxicillin/clavulanic acid (AMC), cefepime (FEP), cefotaxime (CTX), ceftazidime (CAZ), cefuroxime (CXM), ciprofloxacin (CIP), gentamicin (GEN), meropenem (MEM), nitrofurantoin (NIT), piperacillin/tazobactam (TPZ), and sulfamethoxazole-trimethoprim (SXT). Phenotypic detection of ESBLs ESBL screening was carried out by disk diffusion using ceftazidime (30 μg), cefotaxime (30 μg), ceftriaxone (30 μg) or aztreonam (30 μg), in accordance with the recommendations of the CLSI guidelines.13 A combined disk test (CDT) was performed to seek ESBL producers as per CLSI guidelines.13 Discs of ceftazidime (30 μg) and cefotaxime (30 μg) with and without clavulanate (Becton Dickinson, USA) were placed on Mueller-Hinton agar plate (Saudi Prepared Media Laboratory, Riyadh, Saudi Arabia). ESBL phenotype was defined as an increase of ≥5 mm in the zone around the disc containing clavulanate compared to the zone of corresponding discs without clavulanate. Phenotypic detection of carbapenemases The MHT was used to detect carbapenemase production. This test was conducted according to CLSI guidelines. 13 A 0.5 McFarland’s suspension of E coli ATCC 25922 was diluted 1:10 in sterile saline. This was inoculated on a Mueller-Hinton agar plate. An ertapenem disc was placed in the center of the agar plate; 3–5 colonies of the test organism were inoculated in a straight line, from the edge of the disc, up to a distance of at least 20 mm. The plates were incubated at 37°C overnight and examined the next day. Isolates with the cloverleaf images of inhibition were considered carbapenemase-positive isolates. Phenotypic detection of MBLs The isolates that showed reduced susceptibility to imipenem (<27 mm zone size) were selected to screen metallo-β-lactamase (MBL) phenotypically according to CDT method.14 A 0.5 McFarland turbidity standard of overnight culture of the test strain was swabbed on Mueller-Hinton agar plates. Two disks of imipenem without and with 4 μL (of 750 μg) 0.5 M EDTA (ethyl-enediaminetetraacetic acid, Sigma, USA) solution were placed on the plates and the plates were incubated at 35 C0 for 24 hrs. An increase of at least 5 mm around the disc of imipenem containing EDTA than the sizes of the inhibition zones produced by imipenem was recorded as a positive result. Statistical methods Data were stored and analyzed using SPSS 19 (Statistical Package for Social Science; release 19.0). Fishers exact test one way analysis of variance (ANOVA), Kruskal-Wallis test (non-parametric test), chi-square linear trend, chi-square test were used and a P value <.05 was considered as significant. RESULTS Distribution of gram-negative bacteria from the neonatal fecal specimens One hundred fifty fecal specimens from Saudi neonates aged from one day to 7 days were examined for intestinal microbiota. Of 188 gram-negative rods isolated, 165 (87.7%) were oxidase-negative fermentative gram-negative rods, including Enterobacteriaceae: E coli (n=130); K pneumoniae (n=23); E cloacae (n=5); E aerogenes (n=4); M morganii (n=3). Twenty-three (12.2%) of the 188 specimens were non-glucose fermenting gram-negative rods: P aeuroginosa (n=14) and Acinetobacter baumannii (n= 9). E coli strains were the most common isolates in this study and represent 69.1% (n=130/188) of recovered gram-negative rods. From 150 fecal specimens, 20 (15.4%) of 130 E coli strains were recovered as the sole organism. The following organisms were also found: Enterococcus faecalis (n=68/130, 52.3%), K pneumoniae (n=13/130, 10%), A baumannii (n=8/130, 6.1%), P aeuroginosa (n=7/130, 5.4%), E aerogenes (n=4/130, 3.1%). Additionally, E coli was found in association with two other organisms: both E faecalis and K pneumoniae (n=4/130, 3.1%); both E faecalis and P aeuroginosa (n=4/130, 3.1%); both Enterococcus faecalis and Staphylococcus aureus (n=2/130, 1.5%). Distribution of gram-negative bacteria by clinical characteristics of neonates Table 1 shows the effect of the age, mode of delivery, body weights and breastfeeding on the intestinal microbiota. Among the four age groups, the frequency of E coli colonization in group 1 was significantly higher than observed in groups 2, 3, and 4 (P<.03). Among the four age groups, the frequency of K pneumoniae among the neonates increased from 13.3% on day 1 to 23.4% on day 2 and then decreased to 11% in the following days (9.76% in group 3 and 11.77% group 4). The frequency of P aeruginosa among the neonates increased from 2.2% on day 1 to 10.6% on day 2 then slightly decreased to 9.7% on day 3 and then markedly increased to 23.5% in group 4. Frequency of E coli colonization rate among vaginal delivery of neonates (70/78, 89.7%) appeared slightly higher than colonization among those delivered by cesarean (60/72, 83.3%) (P=.249), while the colonization rate of K pneumoniae among virginal delivery of neonates (10/78, 12.8%) appeared slightly lower than its colonization among those delivered by cesarean (13/72, 18.1%)(P=.374). On the other hand, there was a difference between colonization rates of P aeruginosa in vaginal (5/78; 6.4%) and cesarean (9/72; 12.5%) delivery (P=0.2). The results showed that the prevalence of E coli colonization in group 1 (<2 kg) and in group 2 (2–3 kg) were 100% (n=6/6) and 88. 9% (n=56/63), respectively which are significantly higher than its colonization (P=.0001) in other body weight groups with frequencies of 63.26% (n=62/98) and 60% (n=6/10) for groups 3 and 4, respectively. Whereas the influence of feeding type on colonization indicates that the prevalence of E coli, K pneumoniae and P aeruginosa appears slightly higher among neonates with breast feeding as compared with bottle feeding alone or mixed with breastfeeding. Antibiotic susceptibility The resistance patterns for E coli (n=130), K pneumoniae (n=23), E cloacae (n=5), E aerogenes (n=4), M morganii (n=3), P aeruginosa (n=14) and A baumannii (n=9) strains are shown in Table 2. All isolates were susceptible to meropenem and amikacin with the only exception observed in two isolates of E cloacae; 98%, 94%, and 90% of isolates were sensitive to ciprofloxacin, cefepime, and piperacillin/tazobactam, respectively. Prevalence of ESBLs and carbapenemases In the CDT for ESBLs for the 188 gram-negative isolates, 28 (14.9%) had a positive result while the MHT and imipenem/imipenem-EDTA test were positive MBL for 3/188 (1.6%). Three isolates were positive for both the ESBL and metallo-carbapenemases tests (Table 3). ESBL and MBL were not detected in P aeruginosa or A baumannii. Table 3 demonstrates the resistance patterns of 28 ESBL-positive and 160 ESBL-negative strains. DISCUSSION Previous studies have reported fecal carriage of carbapenemase-producing Enterobacteriaceae.6 In Saudi Arabia, to our knowledge, there is not a single report on the fecal colonization of ESBL-, MBLs- and multidrug resistant (MDR) isolates from neonates. Accordingly, we conducted the present study to investigate the prevalence of fecal carriage of ESBLs and carbapenemase-producing gram-negative bacteria among 150 neonates born in two Qassim hospitals, in central Saudi Arabia. We also assessed the risk factors (age in days, mode of delivery, body weight and type of neonatal feeding) on the prevalence of fecal carriage of gram-negative bacteria. In this study, E coli was the most prevalent isolate followed by K pneumonia, which is similar to previous findings in the United States and Mexico.15–18 In Turkey and India, however, K pneumoniae predominates over E coli in neonatal fecal specimens.19,20 The bacterial colonization pattern in the neonatal gut depends on various factors: gestational age, mode of delivery, type of feeding, bacterial interactions, antimicrobial therapy and other environmental factors.15,21 Our results showed that the frequency of E coli colonization in the first day of life was 95%, which was relatively higher than colonization in subsequent days of life. This result demonstrates that E coli colonization during the first days of life is transient. The K pneumoniae colonization rate during the first days of life is apparently different from that of E coli. The frequency of K pneumoniae among the neonates 1 day old was 13% and it increased to 23% on day 2, and then decreased, reaching a plateau of about 11% in the following days for group 3 and group 4. This suggests acquisition later on from the environment rather than acquisition during delivery, whereas the P aeruginosa colonization rate increased in parallel with neonatal age, reaching its maximum colonization by day 4–7. Although other gram-negative rods were limited in number, the trend of colonization behaved more or less similar to that of P aeruginosa. The frequency of E coli colonization with vaginal delivery appears slightly higher than its colonization among those delivered by cesarean delivery, but the frequencies of K pneumoniae (13/72, 18%) and P aeruginosa (9/72, 12.5%) colonization appeared slightly higher among neonates delivered by cesarean than by vaginal delivery (13/72, 18%, 9/72, 12.5%), respectively, suggesting the lack of efficient application of infection control measures and environmental acquisition despite cesarean delivery. Our results are similar to a previous study.22 Our study found that the neonatal microbiota of the gut differ between those delivered by caesarian section and those delivered vaginally. According to Dominguez-Bello et al (2010), upon delivery the neonate is exposed for the first time to a wide array of microbes from a variety of sources, including maternal bacteria, which shapes establishment of the microbiota, and subsequently, its role in child health.1 Thus Goldani et al (2011) found that the obesity rate in adults born by cesarean delivery was 15.2% while in those born by vaginal delivery it was 10.4% (P=.002).23 In a previous study in Switzerland, it was found that an outbreak of ESBL–producing E coli in a neonatal care unit began with transmission from a mother to her newborn twins during vaginal delivery.24 Subsequently, infection spread by healthcare worker contact with other neonates; a healthcare worker also was infected. The present study demonstrates that the prevalence of E coli predominates significantly among neonates with low body weight (<2kg, 6/6, 100%) as compared to higher body weight (>2 kg up to 4 kg, 60% to 89%). Results suggest that neonates with low body weight are highly vulnerable to colonization with E coli as the predominate enteric bacteria. This may explain the frequent implication of E coli neonatal sepsis and/ or meningitis in premature babies who inherently have a lower body weight.18,25 In current study, the influence of feeding type on the neonate’s microbiota seems to indicate that the prevalence of E coli, K pneumoniae and P aeruginosa appears slightly higher among neonates who undergo breastfeeding as compared with bottle feeding alone or mixed with breastfeeding. It has been reported that colonization in breastfed neonates differs from formula fed neonates.15,21 On other hand, some authors have found that the fecal microflora of breastfed and formula fed infants are essentially the same.26 In the present study, the prevalence of P aeruginosa and A. bumannii significantly increased among formula feeding as compared to breast feeding neonates. These findings are compatible with those of a previous study.27 Hence our results would seem to encourage breastfeeding as a major protecting factor for the colonization of such hazardous pathogens. Most of the 188 isolates were sensitive to meropenem (98%), ciprofloxacin (98%), amikacin (98%) and gentamicin (94%). All gram-negative bacterial isolates exhibited high susceptibility against amoxicillin-clavulanate than ampicillin. This finding is consistent with previous studies.19,28 ESBLs are class A enzymes that are inhibited in vitro by β-lactamase inhibitors, whereas those belonging to class B, C and D are not affected.29 ESBL-producing bacteria have spread widely and have become a major cause of nosocomial infections associated with high mortality rates.29,30 A PubMed search found no reports on the prevalence of fecal carriage of ESBL- and MBL-producing strains recovered from neonates in Saudi Arabia. The data presented here provide the first insight into the fecal colonization of ESBL- and carbapenemase-producing strains in Qassim, Saudi Arabia. According to the phenotypic test, the overall prevalence of ESBLs was 15%. This percentage is considered very high in neonates. For comparison, the prevalence of ESBL fecal carriage in the present study was, more or less, in agreement with previous studies.4,5,31–34 The prevalence of ESBLs was different according to the type of organism. In the current study, the prevalences of ESBL among E coli, K pneumoniae, M morganii and E aerogenes were 17%, 4 %, 33%, and 25%, respectively. On the other hand, 60% (3/5) of E cloacae harbored both ESBL and MBL. Meropenem exhibited full activity against all tested strains, with the exception of three E cloacae strains, presumably due to the influence of carbapenemase among these intermediate resistant strains. Fecal colonization in neonatal intensive care units by ESBL and/or MDR bacteria can be a source of nosocomial infections.35 Gram-negative bacteria that exhibited no ESBLs showed fewer MDR patterns in general as compared to positive ESBLs strains, as expected. The risk factors for E cloacae infection in neonates include being small for gestational age, having low birth weight, having ongoing parenteral nutrition, understaffing, over-crowding, poor hygienic practices, contaminated thermometers, presence of E cloacae in the stool and exposure to personnel with contaminated hands.36–38 E cloacae was responsible for several episodes of late neonatal sepsis in very-low-birth-weight neonates in Taiwan.39 The occurrence and detection of MDR strains underline the extraordinary spread of responsible genes among our local enterobacterial strains, and indeed a great deal of these MDR strains can be avoided by the more efficient application of infection control measures, and efficient hand washing. The present study has some limitations, which include absence of molecular characterization of ESBL, and MBL expressed by the bacteria as well as their dissemination sources. Additionally, this study was conducted at only two medical centers in the Qassim area. Therefore, comprehensive multi-center studies in Saudi Arabia are recommended to address the emerging problem of ESBLs and/or MBL-associated infections in order to preserve the continued usefulness of most antimicrobial drugs; and to define the ESBL- and MBL-genotypes as well as epidemiological studies to trace the source of infection. In summary, within the first week of life, the most important determinants of gut enteric bacteria composition in neonates were age-day, body weight, mode of delivery, and type of neonatal feeding. The findings of ESBLs- and MBLs-producing enteric bacteria as neonate-gut colonizers confirms previous studies and may have wider implication or linkage to prevention of nosocomial and community-acquired infections by these strains. Targeted surveillance of high-risk patients and screening is essential to prevent outbreaks; meanwhile in a hospital setting the standard precaustions, primarly hand washing, must be reinforced and rational use of antibiotics should be an obligation. Acknowldegments The authors extend their appreciation to the College of Applied Medical Sciences Research Center and the Deanship of Scientific Research at King Saud University for funding this research. Conflict of interest The authors declared no competing interests. Table 1 Distribution of different gram-negative bacteria by clinical characteristics of subjects. Characteristics Number of neonates Recovered gram negative bacteria (n=188) E coli (n=130) K pneumoniae (n=23) P aeruginosa (n=14) Othersa (n=21) n/% P n/% P n/% P n/% P Age (days) 1 45 43/95.6 .03 6/13.3 .554 1/2.2 .021 8/17.8 .450 2 47 39/83 11/23.4 5/10.6 8/17 3 41 36/87.8 4/9.7 4/9.7 1/2.4 4–7 17 12/70.6 2/11.7 4/23.5 4/23.5 Mode of delivery Vaginal 78 70/89.74 .249 10/12.8 .374 5/6.4 .200 9/11.5 .366 Cesarean 72 60/83.3 13/18.1 9/12.5 12/16.6 Body-weight/kg <2 4 4/100 .0001 1/25 .848 0/0 .002 0/0 .917 2–3 65 58/89.2 11/16.9 3/4.6 8/12.3 3–4 72 62/86.1 7/9.7 6/8.3 13/18.1 >4 9 6/66.6 4/44.4 5/55.5 0/0 Feeding-type Breast 27 26/96.3 .239 8/29.6 .075 3/11.1 .904 0/0 .02 Bottle 83 71/85.5 10/12.1 7/8.4 17/20.5 Mixed 40 33/82.5 5/12.5 4/10 4/10 a A baumannii (n=9), E cloacae (n=5), E aerogenes (n=4) and M morganii (n=3). 1 Chi - Square Linear trend Table 2 Resistance patterns and MIC50/90 of 188 gram negative rods isolated from neonate’s stool. Antibiotic Antibiotic susceptibility pattern E coli (n=130) K pneumoniae (n=23) E cloacae (n=5) E aerogenes (n=4) M morganii (n=3) P aeruginosa (n=14) A baumannii (n=9) R MIC 50/90 R MIC 50/90 R MIC 50/90 R MIC 50/90 R MIC 50/90 R MIC 50/90 R MIC 50/90 No % No % No % No % No % No % No % AMP 73 56.1 16/≥32 23 100 32/≥32 3 60 32/≥32 3 75 8/≥32 3 100 32/≥32 14 100 32/≥32 9 100 16/≥32 AMC 53 40.7 16/≥32 1 5 16/≥32 3 60 16/≥32 3 75 16/≥32 3 100 32/≥32 14 100 16/≥32 7 77.7 16/≥32 TZP 14 1 32/≥128 1 5 128/≥128 3 60 128/≥128 1 25 128/≥128 0 0 4/≥4 2 14 128/≥128 6 66.7 64/≥128 CXM 39 3 16/≥64 1 5 64/≥64 4 80 64/≥64 1 25 64/≥64 3 100 64/≥64 14 100 16/≥64 9 100 32/≥64 FOX 55 4 32/≥64 0 0 4/≥4 4 80 4/≥4 1 25 64/≥64 1 33.3 16/≥16 14 100 64/≥64 9 100 64/≥64 CTX 18 1 16/≥64 1 5 64/≥64 3 60 64/≥64 1 25 64/≥64 1 33.3 16/≥16 14 100 16/≥64 9 100 32/≥64 CAZ 17 13 16/≥64 1 5 16/≥16 3 60 16/≥16 1 25 64/≥64 1 33.3 16/≥16 1 7 16/≥16 0 0 16/≥16 FEP 8 6 8/≥64 1 5 4/≥4 3 60 4/≥4 0 0 1/≥2 0 0 2/≥2 0 0 2/≥16 0 0 1/≥16 MEM 0 0 0.25/≥0.25 0 0 0.25/≥0.25 3 60 2/2 0 0 0.25/≥0.25 0 0 0.25/≥0.25 0 0 0.25/≥0.25 0 0 0.25/≥0.25 AMK 0 0 2/≥4 0 0 2/≥4 3 60 2/≥4 0 0 2/≥2 0 0 2/≥2 0 0 2/≥2 0 0 2/≥2 GEN 8 6 16/≥16 1 5 16/≥16 3 60 16/≥16 0 0 1/≥1 0 0 1/≥1 1 7 16/≥16 0 0 16/≥16 CIP 2 1.5 4/≥4 0 0 0.25/≥0.25 3 60 0.25/≥0.25 0 0 0.25/≥0.25 0 0 0.25/≥0.25 0 0 0.25/≥0.25 0 0 0.25/≥0.25 NIT 65 50 64/≥512 20 87 64/≥128 5 100 64/≥128 4 100 64/≥128 3 100 128/≥128 14 100 16/≥512 9 100 16/≥512 SXT 14 11 80/≥320 1 5 320/≥320 5 100 320/≥320 0 0 20/≥20 0 0 20/≥20 12 86 80/≥160 3 33.3 80/≥160 AMP, ampicillin; AMC, amoxicillin-clavulanic acid; TZP, piperacillin-tazobactam; CAZ, ceftazidime; FEP, cefepime; CXM, cefuroxime; FOX, cefoxitin; CTX, cefotaxime; GEN, gentamicin; AMK, amikacin; CIP, ciprofloxacin; MEM, meropenem; NIT, nitrofurantoin; SXT, sulfamethoxazole-trimethoprim; R=Resistant. Table 3 Resistance patterns of ESBL-positive and ESBL-negative strains isolated from neonates. Antibiotics E coli (n=130) K pneumoniae (n=23%) E cloacae (n=5) E aerogenes (n=4) M morganii (n=1/3; 33%) ESBL positive (n=22/130; 17%) R (%) ESBL negative (n=108/130; 83%) R (%) ESBL positive (n=1/23; 4%) R (%) ESBL negative (n=22/23; 95.6%) R (%) ESBL positive (n=3/5; 60%) R (%) ESBL negative (n=2/5; 40%) R (%) ESBL positive (n=1/4; 25%) R (%) ESBL negative (n=3/4; 75%) R (%) ESBL positive (n=1/3; 33.3%) R (%) ESBL negative (n=2/3; 66.7%) R (%) AMP 22 (100) 69(63.9) 1 (100) 22(100) 3 (100) 0 (0) 1(100) 2(67.7) 1(100) 2 (100) AMC 21(95.5) 32(29.6) 1 (100) 0 (0) 3 (100) 0 (0) 1(100) 2 (67.7) 1(100) 2 (100) TZP 10(45) 4 (3.7) 1 (100) 0 (0) 3 (100) 0 (0) 1(100) 0 (0) 0/0 0 (0) CXM 22(100) 17(15.7) 1 (100) 0 (0) 3 (100) 1 (50) 1(100) 0.0(0) 1(100) 2 (100) FOX 21(95.5) 34(31.5) 0 (0) 0 (0) 3.0(100) 1 (50) 1(100) 3 (100) 1(100) 0 (0) CTX 18(82) 0 (0) 1 (100) 0 (0) 3 (100) 0 (0) 1(100) 0 (0) 1(100) 0 (0) CAZ 17(72) 0 (0) 1 (100) 0 (0) 3 (100) 0 (0) 1(100) 0 (0) 1(100) 0 (0) FEP 8 (36) 0 (0) 1 (100) 0 (0) 3 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) MEM 0 (0) 0 (0) 0 (0) 0 (0) 3 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) AMK 0 (0) 0 (0) 1 (100) 0 (0) 3 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) GEN 3 (13.6) 5 (5) 1 (100) 0 (0) 3 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) CIP 2 (9.1) 0 (0) 0 (0) 0 (0) 3 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) NIT 9(40.9) 56(51.8) 1 (100) 8 (36.4) 3 (100) 2 (100) 1 (100) 3 (100) 1(100) 2 (100) SXT 7(31.8) 7.0(6.5) 1 (100) 0 (0) 3 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) AMP, ampicillin; AMC, amoxicillin-clavulanic acid; TZP, piperacillin-tazobactam; CAZ, ceftazidime; FEP, cefepime; CXM, cefuroxime; FOX, cefoxitin; CTX, cefotaxime; GEN, gentamicin; AMK, Amikacin; CIP, ciprofloxacin; MEM, meropenem; NIT, nitrofurantoin; SXT, sulfamethoxazole-trimethoprim. ==== Refs REFERENCES 1 Dominguez-Bello MG Costello EK Contreras M Magris M Hidalgo G Fierer N Knight R Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns Proc Natl Acad Sci U S A 2010 107 26 11971 5 20566857 2 Mackie RI Sghir A Gaskins HR Developmental microbial ecology of the neonatal gastrointestinal tract Am J Clin Nutr 1999 69 1035S 45S 10232646 3 Donskey CJ The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens Clin Infect Dis 2004 39 2 219 26 15307031 4 Al-Agamy MHM Ali MS Salem MM Mohamed TR Faecal Colonization by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli from Hospitalized Patients 2009 5 Garrido A Seral C Gude MJ Casado C González-Domínguez M Sáenz Y Castillo FJ Characterization of plasmid-mediated beta-lactamases in fecal colonizing patients in the hospital and community setting in Spain Microb Drug Resist 2014 20 4 301 4 24328895 6 Zhao ZC Xu XH Liu MB Wu J Lin J Li B Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital Am J Infect Control 2014 42 5 e61 4 24773806 7 Mirelis B Navarro F Miró E Mesa RJ Coll P Prats G Community transmission of extended-spectrum beta-lactamase Emerg Infect Dis 2003 9 8 1024 5 12971376 8 Al-Agamy MH Shibl AM Hafez MM Al-Ahdal MN Memish ZA Khubnani H Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E coli ST131 Ann Clin Microbiol Antimicrob 2014 7 13 4 9 Chen L Mathema B Chavda KD DeLeo FR Bonomo RA Kreiswirth BN Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding Trends Microbiol 2014 22 12 686 96 25304194 10 Al-Agamy MH Shibl AM Elkhizzi NA Meunier D Turton JF Livermore DM Persistence of Klebsiella pneumoniae clones with OXA-48 or NDM carbapenemases causing bacteraemias in a Riyadh hospital Diagn Microbiol Infect Dis 2013 76 2 214 6 23518186 11 Poirel L Al-Agamy MH Shibl AM Memish Z Couperey F Nordmann P VIM-1 and NDM-1-producing enterobacterial isolates, Saudi Arabia 23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) Berlin 26th to 28th April 2013 1291 12 Collado MC Calabuig M Sanz Y Differences between the Fecal Microbiota of Coeliac Infants and Healthy Controls Curr Issue intestinal micrbiol 2006 8 9 14 13 Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing:24th informational supplement, CLSI document M100-S24 Wayne, PA CLSI 2014 14 Bashir D Thokar MA Fomda BA Bashir G Zahoor D Ahmad S Toboli AS Detection of metallo-beta-lactamase (MBL) producing Pseudomonas aeruginosa at a tertiary care hospital in Kashmir Afr J Microbiol Res 2011 5 2 164 72 15 Penders J Thijs C Vink C Stelma FF Snijders B Kummeling I van den Brandt PA Stobberingh EE Factors influencing the composition of the intestinal microbiota in early infancy Pediatrics 2006 118 2 511 21 16882802 16 Calva JJ Sifuentes-Osornio J Cerón C Antimicrobial resistance in fecal flora:longitudinal community-based surveillance of children from urban Mexico Antimicrob Agents Chemother 1996 40 7 1699 702 8807065 17 Jost T Lacroix C Braegger CP Chassard C New lnsights in Gut Microbiota Establishment in Healthy Breast Fed Neonates PloS One 2012 7 8 e44595 22957008 18 Sharma N Chaudhry R Panigrahi P Quantitative and qualitative study of intestinal flora in neonates J Glob Infect Dis 2012 4 4 188 92 23326075 19 Duman M Abacioglu H Karaman M Duman N Özkan H beta-lactam antibiotic resistance in aerobic commensal fecal flora of newborns Pediatrics International 2005 47 3 267 73 15910449 20 Das P Singh AK Pal T Dasgupta S Ramamurthy T Basu S Colonization of the gut with Gram-negative bacilli, its association with neonatal sepsis and its clinical relevance in a developing country J Med Microbiol 2011 60 11 1651 60 21719575 21 Huurre A Kalliomäki M Rautava S Rinne M Salminen S Isolauri E Mode of Delivery-effects on gut microbiota and humoral immunity Neonatol 2008 93 236 40 22 Azad MB Konya T Maughan H Guttman DS Field CJ Chari RS Sears MR Becker AB Scott JA Kozyrskyj AL 2013 Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months CMAJ 3 185 5 385 94 23401405 23 Goldani HAS Bettiol H Barbieri MA Silva AAM Agranonik M Morais MB Goldani MZ 2011 Cesarean delivery is associated with an increased risk of obesity in adulthood in a Brazilian birth cohort study Am J Clin Nutr 93 6 1344 1347 21508088 24 Tschudin-Sutter S Frei R Battegay M Hoesli I Widmer AF 2010 Extended spectrum ß-lactamase-producing Escherichia coli in neonatal care unit Emerg Infect Dis 16 11 1758 60 21029537 25 Kaczmarek A Budzyńska A Gospodarek E The occurrence of Escherichia coli with K1 surface antigen in pregnant women and in newborns Med Dosw Mikrobiol 2010 62 1 59 65 20564972 26 Thompson-Chagoyan OC Maldonado J Gil A Colonization and impact of disease and other factors on intestinal microbiota Dig Dis Sci 2007 52 2069 77 17420934 27 Nelson RK Poroyko V Morowitz MJ Liu D Alverdy JC Effect of dietary monosaccharides on Pseudomonas aeruginosa virulence Surg Infect 2012 14 1 35 42 28 Yang CM Lin MF Lin CH Huang YT Hsu CT Liou ML Characterization of antimicrobial resistance patterns and integrons in human fecal Escherichia coli in Taiwan Jpn J Infect Dis 2009 62 3 177 81 19468175 29 Curello J MacDougall C Beyond Susceptible and Resistant, Part II: Treatment of Infections Due to Gram-Negative Organisms ProducingExtended-Spectrum Beta-Lactamases J Pediatr Pharmacol Ther 2014 19 3 156 64 25309145 30 Bjorn B Jureen R Manji KP Tamim BS Mwakagile DSM Urassa WK Fataki M Msangi V Tellevik MG Maselle SY Langeland N High Rate of Fatal Cases of Pediatric Septicemia Caused by Gram-Negative Bacteria with Extended-Spectrum Beta-Lactamases in Dar es Salaam, Tanzania J Clin Microbiol 2005 43 745 9 15695674 31 Singh NK Patel M Leger MM Risk of resistant infections with Enterobacteriaceae in hospitalized neonates Pediatr Infect Dis J 2002 21 1029 33 12442024 32 Kader AA Kumar A Kamath KA Fecal carriage of extended spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals Infect Control Hosp Epidemiol 2007 28 1114 6 17932839 33 Kiremitci A Dinleyici EC Yargic ZA Durmaz G Tekin N Aybey AD Aksit MA Prevalence and Risk Factors of Fecal Carriage of Extended-Spectrum beta-lactamase (ESBL) -Producing Enterobacteriaceae in Hospitalized and Ambulatory Children J Pediatr Inf 2011 5 54 8 34 Desimoni MC Esquivel GP Merino LA Fecal colonization by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit Enferm Infecc Microbiol Clin 2004 22 9 507 11 15511390 35 Moyo S Aboud S Kasubi M Lyamuya E Maselle S Antimicrobial resistance among producers and non-producers of extended spectrum beta-lactamases in urinary isolates at a tertiary Hospital in Tanzania BMC Res Notes 2010 3 348 21184671 36 Yu WL Cheng HS Lin HC Peng CT Tsai CH Outbreak inves-tigation of nosocomial Enterobacter cloacae bacteraemia in a neonatal intensive care unit Scand J Infect Dis 2000 32 293 8 10879601 37 Fok TF Lee CH Wong EM Risk factors for Enterobacter septicemia in a neonatal unit: case-control study Clin Infect Dis 1998 27 1204 9 9827270 38 Harbarth S Sudre P Dharan S Cadenas M Pittet D Outbreak of Enterobacter cloacaerelated to understaffing, overcrowding, and poor hygiene practices Infect Control Hosp Epidemiol 1999 20 598 603 10501256 39 Chen HN Lee ML Yu WK Lin YW Tsao LY Late-onset Enterobacter cloacae sepsis in very-low-birth-weight neonates: experience in a medical center Pediatr Neonatol 2009 50 1 3 7 19326831